Tag: Sun Pharma

Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug

Posted on By admin
Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug

Sun Pharmaceutical Industries and LIB Therapeutics Inc on Monday announced an exclusive licensing agreement granting the Indian drug maker rights to commercialise and manufacture lerodalcibep worldwide, excluding the U.S. and China. The agreement establishes a new growth platform for it in a large and rapidly expanding market, Sun Pharma said. IQVIA numbers show the PCSK9…

Read More “Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug” »

Business

Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes

Posted on By admin
Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes

Sun Pharmaceutical Industries Ltd., in Mumbai, India | Photo Credit: Reuters Sun Pharmaceutical Industries will extend Most Favoured Nation (MFN) pricing to state medicaid programmes of the U.S. It has also committed to MFN pricing for future innovative medicine launches. The announcement followed a White House ceremony on August 31, in which the U.S. government…

Read More “Sun Pharma agrees to supply at MFN pricing to U.S. medicaid programmes” »

Business

Sun Pharma gets favourable verdict in antitrust-litigation in U.S.

Posted on By admin
Sun Pharma gets favourable verdict in antitrust-litigation in U.S.

Image used for representational purposes. | Photo Credit: Reuters Sun Pharmaceutical Industries on Monday (August 17, 2026) said an appellate court in the United States has passed a judgment in favour of the company and its subsidiaries in the antitrust litigation, in the U.S., relating to a 2008 patent litigation settlement agreement with Pfizer concerning…

Read More “Sun Pharma gets favourable verdict in antitrust-litigation in U.S.” »

Business

Sun Pharma gets Brazil nod for Semaglutide

Posted on By admin
Sun Pharma gets Brazil nod for Semaglutide

Sun Pharmaceutical Industries has received Brazilian Health Regulatory Agency ANVISA approval to manufacture and market semaglutide injection in the Latin American country. The generic drugmaker plans to launch the product in the next few days in partnership with Hypera Pharma, a pharmaceutical company in Brazil. It will be available as a pre‑filled, multi‑dose injectable pen…

Read More “Sun Pharma gets Brazil nod for Semaglutide” »

Business

Gautam Adani Emerges As Biggest Dollar Gainer In Forbes Rich List 2024

Posted on By admin
Gautam Adani Emerges As Biggest Dollar Gainer In Forbes Rich List 2024

With his brother Vinod, Gautam Adani added $48 billion to take the familys net worth to $116 billion New Delhi: Adani Group chairman Gautam Adani emerged as the biggest dollar gainer on Thursday among the list of Forbes India’s 100 richest tycoons, with the family’s net worth rising to $116 billion. Along with his brother…

Read More “Gautam Adani Emerges As Biggest Dollar Gainer In Forbes Rich List 2024” »

Nation